Top Analyst Upgrades and Downgrades: Coupons.com, Dean Foods, Hilton, Isis Pharma, NOV, Stratasys and More
Goodrich Petroleum Corp. (NYSE: GDP) was downgraded to Hold from Buy at Canaccord Genuity.
Hilton Worldwide Holdings Inc. (NYSE: HLT) was raised to Outperform from Neutral at Baird.
Iconix Brand Group Inc. (NASDAQ: ICON) was raised to Buy from Hold at Brean Capital.
Isis Pharmaceuticals Inc. (NASDAQ: ISIS) was downgraded to Neutral from Overweight at Piper Jaffray.
Myriad Genetics Inc. (NASDAQ: MYGN) has multiple calls after beating earnings but tempering guidance, and after the CEO is retiring. Myriad was raised to Outperform from Market Perform at JMP Securities. It was also downgraded to Underperform from Neutral at Credit Suisse and to Neutral from Buy at Mizuho.
National Oilwell Varco Inc. (NYSE: NOV) was downgraded to Neutral from Buy at Sterne Agee.
Pacific Coast Oil Trust (NYSE: ROYT) was downgraded to Equal Weight from Overweight and the price target was slashed to $6 from $11 (versus a $5.43 close) at Barclays.
Pentair PLC (NYSE: PNR) posted earnings above estimates, but revenues were soft. The manufacturer was downgraded to Hold from Buy at KeyBanc Capital Markets and to Market Perform from Outperform at Bernstein.
Stratasys Ltd. (NASDAQ: SSYS) already saw negative analyst calls on Tuesday after its dire warning, but the 3D printing player was downgraded to Hold from Buy at Stifel and to Equal Weight from Overweight at Morgan Stanley.
Waddell & Reed Financial Inc. (NYSE: WDR) traded lower despite headlines saying it beat earnings expectations. The investment firm was downgraded to Sell from Neutral at Citigroup and to Neutral from Buy at Sterne Agee.
In case you missed Tuesday’s top analyst upgrades and downgrades, they included Barclays, Caterpillar, EMC, JD.com, LinkedIn, Stratasys and over a dozen more companies.